等待开盘 09-18 09:30:00 美东时间
0.000
0.00%
BTIG analyst Sam Eiber reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $18 price target.
09-08 23:49
Evolus (NASDAQ:EOLS) has appointed Tatjana Mitchell as its chief financial officer, effective September 8, 2025. EOLS -0.52% premarket to $7.62. Source: Press Release More on Evolus Evolus - A Slightl...
09-08 20:58
①尽管烈日当空,但对美国中产阶级而言,这个夏天的信心却在持续降温; ②密歇根大学上周公布的一项备受关注的调查显示,美国消费者信心指数在6月和7月持续攀升后,8月骤降了近6%。
09-01 15:30
Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it has submitted the final module of its Premarket Approval (PMA)
08-20 20:04
Needham analyst Serge Belanger downgrades Evolus (NASDAQ:EOLS) from Buy to Hold and maintains the price target from $22 to $22.
08-06 20:34
Shares of Astera Labs, Inc. (NASDAQ:ALAB) rose sharply in pre-market trading af...
08-06 17:35
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
The latest update is out from Evolus ( ($EOLS) ). On August 1, 2025, Evolus app...
08-06 04:47
Evolus (NASDAQ:EOLS) lowers FY2025 sales outlook from $345.000 million-$355.000 million to $295.000 million-$305.000 million vs $348.308 million estimate.
08-06 04:19
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32